Journal of Oral and Maxillofacial Surgery
Volume 65, Issue 2 , Pages 177-185 , February 2007

Does Prophylactic Administration of Systemic Antibiotics Prevent Postoperative Inflammatory Complications After Third Molar Surgery?

  • Leslie R. Halpern, DDS, MD, PhD, MPH

      Affiliations

    • Assistant Professor, Department of Oral and Maxillofacial Surgery, Massachusetts General Hospital, Boston, MA.
    • Corresponding Author InformationAddress correspondence and reprint requests to Dr Halpern: Department of Oral and Maxillofacial Surgery, Massachusetts General Hospital, 55 Fruit Street, Warren 1201, Boston, MA 02114
    • ,
  • Thomas B. Dodson, DMD, MPH

      Affiliations

    • Associate Professor, Visiting Oral and Maxillofacial Surgeon, Department of Oral and Maxillofacial Surgery, Harvard School of Dental Medicine; Director, Center for Applied Clinical Investigation in Oral and Maxillofacial Surgery, Massachusetts General Hospital, Boston, MA.

References 

  1. Lieblich SE. Postoperative prophylactic antibiotic treatment in third molar surgery—A necessity?. J Oral Maxillofac Surg. 2004;62:9
  2. Poeschl WP, Eckel D, Poeschl E. Postoperative prophylactic antibiotic treatment in third molar surgery—A necessity?. J Oral Maxillofac Surg. 2004;62:3
  3. Thomas DW, Hill CM. An audit of antibiotic prescribing in third molar surgery. Br J Oral Maxillofac Surg. 1997;35:126
  4. Flick W. The third molar controversy: Framing the controversy as a public health policy issue. J Oral Maxillofac Surg. 1999;57:438
  5. Epstein JB, Chong S, Le N. A survey of antibiotic use in dentistry. JADA. 2000;131:1600
  6. Foy SP, Shugars DA, Phillips C, et al. The impact of intravenous antibiotics on health-related quality of life outcomes and clinical recovery after third molar surgery. J Oral Maxillofac Surg. 2004;62:15
  7. Piecuch JF, Arzadon J, Lieblich SE. Prophylactic antibiotics for third molar surgery: A supporting opinion. J Oral Maxillofac Surg. 1995;53:53
  8. Sekhar CH, Naraynam M, Baig F. Role of antimicrobials in third molar surgery: Prospective, double blind, randomized, placebo-controlled clinical study. Br J Oral Maxillofac Surg. 2001;39:134
  9. Zeitler DL. Prophylactic antibiotics for third molar surgery: A dissenting opinion. J Oral Maxillofac Surg. 1995;53:61
  10. Curran JB, Kennett S, Young AR. An assessment of the use of prophylactic antibiotics in third molar surgery. Int J Oral Surg. 1974;3:1
  11. Dodson TB: Evidence-based clinical practice: Clinical decision-making with imperfect science, in Felsenfeld AL, Rafetto LK (eds): AAOMS Knowledge Update, Volume 4. Rosemont, IL, American Association of Oral and Maxillofacial Surgery: (Publication pending)
  12. Blum IR. Contemporary views on dry socket (alveolar osteitis): A clinical appraisal of standardization, aetiopathogenesis and management by a critical review. Int J Oral Maxillofac Surg. 2002;31:309
  13. Fridrich KL, Olson B. Alveolar osteitis following surgical removal of mandibular third molars. Anesth Prog. 1990;37:32
  14. Shiau HJ, Dewhirst FE. IADR/AADR/CADR/Meeting, 2005, Baltimore MD (Microbiota associated with normal healing extraction wounds and alveolar osteitis). J Dental Res 84 (Special Issue A). 2005;3458
  15. Larsen PE. Alveolar osteitis after surgical removal of impacted mandibular third molars: Identification of the patient at risk. Oral Surg Oral Med Oral Pathol. 1992;73:393
  16. Andra A, Ahrens HG, Schwerdtfger K. Economic aspects of alveolitis. Stomatol DDR. 1990;40:308
  17. Swanson AE. Prevention of dry socket: An overview. Oral Surg Oral Med Oral Pathol. 1990;70:131
  18. Landes DP. The relationship between dental health and variations in the level of third molar removals experienced by populations. Community Dent Health. 1998;15:67
  19. Dodson TD. HIV status and the risk of post-extraction complications. J Dent Res. 1997;76:1644
  20. Dodson TB. Prediction of post extraction complications in HIV positive patients. Oral Surg Oral Med Oral Pathol. 1997;84:474
  21. Perrott DH, Yuen JP, Andresen RV, et al. Office-based ambulatory anesthesia: Outcome of clinical practice in oral and maxillofacial surgeons. J Oral Maxillofac Surg. 2003;61:983
  22. Bratzler DW, Houck PM. Antimicrobial prophylaxis for surgery: An advisory statement from the national surgical infection prevention project. Clin Infect Dis. 2004;38:1706
  23. Tunis SR, Stryer DB, Clancy CM. Practical clinical trials: Increasing the value of clinical research for decision making in clinical and health policy. JAMA. 2003;290:1624
  24. Egger M, Juni P, Bartlett C CONSORT Group. The value of patient flow charts in reports of randomized controlled trials: Bibliographic study. JAMA. 2001;285:1996
  25. Haug RH, Perrott DA, Gonzalez ML, et al. The American Association of Oral and Maxillofacial Surgeons age-related third molar study. J Oral Maxillofac Surg. 2005;63:1106
  26. Rita M, Hillarie S, Bromberg PE, et al. Does metronidazole prevent alveolitis sicca dorolosa? (A double-blinded, placebo-controlled clinical study). Int J Oral Maxillofac Surg. 1992;21:299
  27. Mitchell DA. A controlled clinical trial of prophylactic tinidazole for chemoprophylaxis in third molar surgery. Br Dent J. 1986;160:284

 This study was supported in part by the Oral and Maxillofacial Surgery Foundation Research Grant and Massachusetts General Hospital (MGH) Center for Applied Clinical Investigation.

PII: S0278-2391(06)01908-2

doi: 10.1016/j.joms.2006.10.016

Journal of Oral and Maxillofacial Surgery
Volume 65, Issue 2 , Pages 177-185 , February 2007

Article Tools

* Image Usage & Resolution